• Merit Medical Systems adopted the 2026 Equity Incentive Plan, effective May 13, 2026, replacing its prior equity plan framework for new awards.
• The plan authorizes a share reserve of 2,700,000 common shares for equity awards, with forfeited or unissued shares recycled back into the pool.
• Non-employee director awards are capped at USD 750,000 in aggregate value per fiscal year, rising to USD 1 million in a director’s initial fiscal year of service.
• Awards generally carry minimum vesting of at least one year, or 350 days for non-employee directors.
• Option and stock appreciation right terms run up to seven years, with option repricing restricted unless shareholders approve.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Merit Medical Systems Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0000856982-26-000030), on May 19, 2026, and is solely responsible for the information contained therein.